RLJ Lodging Trust股票討論區

$RLJ Lodging Trust(RLJ.US)$營收在2020年大幅萎縮70%，之後兩年快速恢復，2022年達到2019年的76%，營業利潤在2020和2021年虧損兩年，2022年扭虧達到2019年的52%，淨利潤也類似，2022年達到2019年的33%。
2023前兩季度營收增長17.1%，營業利潤增長60%，淨利潤增長近兩倍。
長期借款22.19億，是24億淨資產的92%，槓桿率在板塊內比較正常。
5年來現金流經營淨額累計大幅超過投資淨額，股東盈餘較多。
目前市盈率101.5，市盈率TTM降到了31.7，如果不計算疫情的兩年，另外3年平均淨利潤爲1.2億，對應市盈率爲13.3，股息率2.6%，市淨率0.79，總體吸引力不大。

Upgrades
• $飛塔信息(FTNT.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $350 (from $325)
• $微芯科技(MCHP.US)$ : Stifel Upgrades to Buy from Hold - PT $75 (from $70)
• $Ovintiv(OVV.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $64 (from $56)
• $Riot Platforms(RIOT.US)$ : Compass Point Upgrades to Buy from Neutral - PT $14 (from $30)
• $Snowflake(SNOW.US)$ : Jefferies Upgrades to Buy f...

Upgrades
• $美國航空(AAL.US)$ : JP Morgan Upgrades to Neutral From Underweight - PT $26 (from $18)
• $The AZEK(AZEK.US)$ : Citigroup Upgrades to Buy from Neutral - PT $30 (from $36)
• $波士頓物產(BXP.US)$ : Mizuho Upgrades to Buy from Neutral - PT $135 (from $120)
• $陶氏化學(DOW.US)$ : Citigroup Upgrades To Buy From Neutral - PT $82 (from $70)
• $克羅格(KR.US)$ : Exane Upgrades to Neutral from Underperform - PT $60
• $Milestone Pharmaceuticals(MIST.US)$ : Piper S...